Schizophrenia: one lot of paliperidone extended-release recalled
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Teva Pharmaceuticals has issued a recall of a single lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A, expiration 6/2018, NDC 0591-3693-19.
Why this matters
- The lot failed a dissolution test, which could result in less drug absorbance and reduced efficacy.
- Teva Pharmaceuticals USA initially recalled the lot ...